Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche Diagnostics, Redcliffe Labs collaborate for early Alzheimer's prediction

Ruchika Sharma4 Nov 2022 11:21 AM IST

New Delhi: Redcliffe Labs has partnered with Roche Diagnostics India to offer a combination of Roche Diagnostics' biomarker testing with Redcliffe...

Biological E Corbevax safe, immunogenic in 5-18 age group

Ruchika Sharma3 Nov 2022 4:30 PM IST

Hyderabad: Biological E. Limited, a Hyderabad-based vaccine, and pharmaceutical company, today announced the publication of CORBEVAX COVID-19 vaccine...

Ayurveda doctor fined Rs 50,000 for advertising product, making cure claims through social media ads

Religare Finvest fund diversion case: SEBI slaps Rs 21 crore fine on 52 entities including Fortis Healthcare Holdings

Ruchika Sharma3 Nov 2022 2:30 PM IST

New Delhi: Capital markets regulator Sebi has imposed a fine totalling Rs 21 crore on 52 entities, including Fortis Healthcare Holdings, in a case...

Senores Pharma arm facility gets 3 USFDA observations

Lupin Tarapur facility gets USFDA warning letter

Ruchika Sharma3 Nov 2022 1:30 PM IST

"This warning letter summarises significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API),"...

Alembic Pharma gets four USFDA observations for Panelav facility

Alembic Pharma bags USFDA approval for Pain relief injection Ketorolac Tromethamine

Ruchika Sharma3 Nov 2022 12:30 PM IST

Ketorolac Tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain in adult patients.

Glenmark Pharma gets USFDA nod for generic version of Buphenyl tablets

Ruchika Sharma3 Nov 2022 11:15 AM IST

BUPHENYL is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark unveils generic version of Gilenya Capsules in US

Ruchika Sharma2 Nov 2022 2:30 PM IST

Mumbai: Drugmaker Glenmark Pharmaceuticals Inc., USA, has recently announced the launch of Fingolimod Capsules, 0.5 mg in the US. The...

Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue Sarcoma

Sun Pharma reports 10.5 percent rise in Q2 profit

Ruchika Sharma2 Nov 2022 2:30 PM IST

Bengaluru: Sun Pharmaceutical Industries Ltd, India's largest drugmaker, on Tuesday reported a surprise 10.5 percent rise in second-quarter profit led...

DNB Community Medicine in India: Check out NBE released Curriculum

Ruchika Sharma2 Nov 2022 2:00 PM IST

The National Board of Examinations (NBE) has released the Curriculum for DNB Community Medicine. I. OBJECTIVES OF THE PROGRAMME: 1. Programme...

Persisting cost inflation, pricing pressures impact pharma industry, minimal impact of European market headwinds thus far: ICRA

Ruchika Sharma2 Nov 2022 1:30 PM IST

New Delhi: ICRA's sample set of 16 Indian pharmaceutical companies registered revenue growth of 4.9% YoY in Q1 FY2023. This was supported by 4.2%...

USFDA nod to JnJ Tremfya for Crohns disease

Johnson and Johnson to acquire Abiomed for USD 16.6 billion to boost cardiovascular business

Ruchika Sharma2 Nov 2022 12:30 PM IST

New Brunswick: Johnson & Johnson and Abiomed have entered into a definitive agreement under which Johnson & Johnson will acquire through a...

Alembic Secures USFDA Nod for Durezol Generic Difluprednate

Alembic Pharma secures USFDA okay for Mesalamine ER Capsules

Ruchika Sharma2 Nov 2022 11:18 AM IST

Mesalamine Extended-Release Capsules are indicated for the maintenance of remission of ulcerative colitis in adults.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok